reiterateGILDfinnhub
Morgan Stanley Reiterates Overweight Rating on Gilead Sciences, Inc. (GILD)
Morgan Stanley reiterated its Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on October 07, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Morgan Stanley reiterated its Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on October 07, 2026.
Read moreTruist Securities reiterated its Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) on October 07, 2026.
Read moreJP Morgan reiterated its Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on October 07, 2026.
Read moreBarclays reiterated its Overweight rating on Danaher Corporation (NYSE:DHR) on October 07, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Booking Holdings Inc. (NASDAQ:BKNG) on October 07, 2026.
Read moreBarclays reiterated its Overweight rating on BlackRock, Inc. (NYSE:BLK) on October 07, 2026.
Read moreKurtz George, of CrowdStrike Holdings, Inc. Class A Common Stock (NASDAQ:CRWD), sold 1,455 shares of company stock on October 02, 2026, according to a Form 4 filing with the…
Read moreBarclays reiterated its Overweight rating on The Charles Schwab Corporation (NYSE:SCHW) on October 07, 2026.
Read moreWadecki Adam A, of Eaton Corporation plc (NYSE:ETN), sold 390 shares of company stock on October 02, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
Read moreUBS reiterated its Buy rating on The Charles Schwab Corporation (NYSE:SCHW) on October 07, 2026.
Read moreBTIG reiterated its Buy rating on Uber Technologies, Inc. (NYSE:UBER) on October 07, 2026.
Read moreCitizens reiterated its Market Outperform rating on Uber Technologies, Inc. (NYSE:UBER) on October 07, 2026.
Read moreArgus Research reiterated its Buy rating on ServiceNow, Inc. (NYSE:NOW) on October 07, 2026.
Read moreCitigroup reiterated its Buy rating on Linde plc (NASDAQ:LIN) on October 07, 2026.
Read moreBarclays analysts initiated coverage on Intuitive Surgical, Inc. (NASDAQ:ISRG) with a rating of Overweight on October 07, 2026.
Read moreBarclays analysts initiated coverage on Abbott Laboratories (NYSE:ABT) with a rating of Overweight on October 07, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Amgen Inc. (NASDAQ:AMGN) on October 07, 2026.
Read moreTruist Securities reiterated its Hold rating on Amgen Inc. (NASDAQ:AMGN) on October 07, 2026.
Read moreBarclays reiterated its Overweight rating on Thermo Fisher Scientific Inc. (NYSE:TMO) on October 07, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Merck & Co., Inc. (NYSE:MRK) on October 07, 2026.
Read more